# Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin

> **NCT02423356** · — · COMPLETED · sponsor: **Daniel Rushing** · enrollment: 12 (actual)

## Conditions studied

- Breast Neoplasms
- Lymphoma
- Sarcoma

## Interventions

- **PROCEDURE:** Echocardiogram

## Key facts

- **NCT ID:** NCT02423356
- **Lead sponsor:** Daniel Rushing
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-23
- **Primary completion:** 2018-02-01
- **Final completion:** 2018-02-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02423356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02423356, "Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02423356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*